Andrew Bruce

Andrew Bruce has extensive experience in bioprocess research and development, currently working at ProKidney Corp. since February 2023. Previously, Andrew served as Senior Director of Scientific Operations at Zen-Bio, Inc. and held various senior leadership roles in process and product development at OrganaBio, LLC and United Therapeutics Corporation, where responsibilities included overseeing the regenerative medicine lab. Andrew began a career in biotechnology as a Scientist at Tengion and Vesta Therapeutics, focusing on regenerative medicine technologies and cell therapies, and previously worked as a Senior Research Associate at Incara Pharmaceuticals, contributing to liver cell therapy development. Educational background includes a Bachelor of Science in Zoology from North Carolina State University.